Phase 2 data presented at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting show deep and durable tumor regressions in heavily pre-treated melanoma patients, with a mild safety ...

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

RANI READ THE FULL RANI RESEARCH REPORT With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and ...

The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract ...

Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Six out of 10 cancer patients who took part in a clinical trial preferred a subcutaneous injection formulation that improves the existing dosing method of Keytruda, an anticancer drug from Merck (MSD) ...

Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

A modder has made an even bigger improvement to Grand Theft Auto IV than Fusion Fix. xoxor4d created an Nvidia RTX Remix build for the game that runs on path traced graphics. This makes it the most ...

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

TP-Link is warning of two command injection vulnerabilities in Omada gateway devices that could be exploited to execute arbitrary OS commands. Omada gateways are marketed as full-stack solutions ...